Settlement and License Agreement
Drafts an agreement that simultaneously resolves IP litigation and establishes a licensing framework between the parties.
Prerequisites
- Case documents — pleadings, complaints, counterclaims, case numbers, court identifications
- IP portfolio — patent numbers, trademark registrations, copyright registrations, trade secret descriptions
- Prior negotiations — term sheets, settlement correspondence, mediation briefs
- Financial terms — agreed settlement amounts, proposed royalty structures, payment schedules
- Party details — full legal names, entity types, jurisdictions of organization, principal places of business
Output Structure
1. Preamble and Recitals
| Element |
Content |
| Parties |
Full legal names, entity types, organization jurisdictions, addresses, signing capacity |
| Dispute history |
Case numbers, courts, claims asserted, IP at issue |
| Recital narrative |
Context sufficient for a third party to understand what was settled and why |
| Mutual intent |
Desire to resolve disputes and establish licensing relationship |
2. Definitions
Define all key terms on first use. At minimum:
- Licensed IP (enumerate by registration/patent number)
- Licensed Field of Use
- Licensed Territory
- Net Sales / Royalty Base
- Confidential Information
- Affiliate / Related Party
3. Settlement and Release
| Component |
Requirements |
| Mutual general release |
Scope: all claims asserted or assertable; extend to affiliates, successors, assigns; carve out obligations under this agreement |
| Covenant not to sue |
Additional layer beyond the release |
| Litigation dismissal |
Stipulated dismissal with prejudice; specify timeline and filing responsibility |
| Survival |
Release must survive license termination — draft explicit language |
- Balance breadth (finality) against specificity (enforceability)
- Include Cal. Civ. Code § 1542 waiver or equivalent if California law applies [VERIFY]
4. License Grant
| Parameter |
Address |
| IP type |
Patents (by number), trademarks (by reg. no. + common law), copyrights, trade secrets, know-how |
| Exclusivity |
Exclusive, non-exclusive, or sole |
| Field of use |
Product categories, industries, applications |
| Territory |
Geographic scope |
| Duration |
Term of years, perpetual, or patent life |
| Sublicensing |
Permitted? Sublicense survival on termination? |
| Improvements |
Included? Derivative ownership? Grant-back provisions? |
5. Financial Terms
Distinguish settlement consideration from license royalties — different tax treatment.
Settlement payments:
- Lump sum amount and payment schedule
- Characterization (damages vs. license consideration vs. both)
- Tax treatment allocation
Ongoing royalties:
6. Confidentiality
7. Representations, Warranties, and Indemnification
| Party |
Representations |
| Mutual |
Authority to enter agreement; no conflict with existing obligations |
| Licensor |
Ownership of licensed IP; right to grant license; no known third-party infringement (knowledge qualifier) |
| Licensee |
Ability to perform obligations; compliance with applicable laws |
Indemnification: scope of covered claims, notice requirements, control of defense, liability caps, consequential damages exclusion, "as-is" disclaimer where appropriate.
8. Term, Termination, and Post-Termination
| Provision |
Settlement Component |
License Component |
| Duration |
Irrevocable on execution |
Defined term or perpetual |
| Termination triggers |
N/A |
Material breach, non-payment, bankruptcy |
| Cure period |
N/A |
30 days written notice (standard) |
| Post-termination |
Release survives |
Cease use, wind-down period, inventory sell-off |
| Surviving provisions |
Release, confidentiality |
Audit rights, accrued payments |
Critical: License termination must NOT revive settled claims.
9. Dispute Resolution
| Step |
Timeframe |
| Executive negotiation |
15–30 days |
| Mediation |
30–60 days |
| Binding arbitration or litigation |
Per rules selected |
Specify: governing law, venue/arbitration seat, arbitration rules (AAA, JAMS, ICC), prevailing party fee-shifting, jury trial waiver (if litigation path), whether settlement vs. license disputes use different mechanisms.
10. General Provisions
Guidelines
- Release–license interaction — Always address whether the release survives license termination. Ambiguity here risks revived claims.
- Tax characterization — Settlement payments and royalties differ in tax treatment. Flag for tax counsel.
- Antitrust risk — License-back provisions and field-of-use restrictions in settlement context may raise antitrust concerns. Flag if present.
- Bankruptcy — IP licenses receive special treatment under 11 U.S.C. § 365(n) [VERIFY]. Include licensee protective language.
- Recording — Patent and trademark licenses may require USPTO recording. Include cooperation obligation.
- Internal consistency — Cross-check defined terms, section cross-references, and numbering before final output.
- No legal advice — Flag all jurisdiction-specific provisions for attorney review. Settlement agreements require human oversight.
1---2name: settlement-license-agreement3description: Drafts a dual-purpose Settlement and License Agreement resolving IP litigation while establishing an ongoing licensing framework. Covers mutual releases, covenants not to sue, IP license grants, royalty structures, confidentiality, indemnification, and post-termination rights. Use when drafting IP settlement agreements, litigation resolution with license-back provisions, or combined release-and-license instruments.4tags:5 - litigation6 - transactional7 - agreement8 - drafting9---1011# Settlement and License Agreement1213Drafts an agreement that simultaneously resolves IP litigation and establishes a licensing framework between the parties.1415## Prerequisites16171. **Case documents** — pleadings, complaints, counterclaims, case numbers, court identifications182. **IP portfolio** — patent numbers, trademark registrations, copyright registrations, trade secret descriptions193. **Prior negotiations** — term sheets, settlement correspondence, mediation briefs204. **Financial terms** — agreed settlement amounts, proposed royalty structures, payment schedules215. **Party details** — full legal names, entity types, jurisdictions of organization, principal places of business2223## Output Structure2425### 1. Preamble and Recitals2627| Element | Content |28|---|---|29| Parties | Full legal names, entity types, organization jurisdictions, addresses, signing capacity |30| Dispute history | Case numbers, courts, claims asserted, IP at issue |31| Recital narrative | Context sufficient for a third party to understand what was settled and why |32| Mutual intent | Desire to resolve disputes and establish licensing relationship |3334### 2. Definitions3536Define all key terms on first use. At minimum:37- Licensed IP (enumerate by registration/patent number)38- Licensed Field of Use39- Licensed Territory40- Net Sales / Royalty Base41- Confidential Information42- Affiliate / Related Party4344### 3. Settlement and Release4546| Component | Requirements |47|---|---|48| Mutual general release | Scope: all claims asserted or assertable; extend to affiliates, successors, assigns; carve out obligations under this agreement |49| Covenant not to sue | Additional layer beyond the release |50| Litigation dismissal | Stipulated dismissal with prejudice; specify timeline and filing responsibility |51| Survival | Release must survive license termination — draft explicit language |5253- Balance breadth (finality) against specificity (enforceability)54- Include Cal. Civ. Code § 1542 waiver or equivalent if California law applies [VERIFY]5556### 4. License Grant5758| Parameter | Address |59|---|---|60| IP type | Patents (by number), trademarks (by reg. no. + common law), copyrights, trade secrets, know-how |61| Exclusivity | Exclusive, non-exclusive, or sole |62| Field of use | Product categories, industries, applications |63| Territory | Geographic scope |64| Duration | Term of years, perpetual, or patent life |65| Sublicensing | Permitted? Sublicense survival on termination? |66| Improvements | Included? Derivative ownership? Grant-back provisions? |6768### 5. Financial Terms6970Distinguish settlement consideration from license royalties — different tax treatment.7172**Settlement payments:**73- Lump sum amount and payment schedule74- Characterization (damages vs. license consideration vs. both)75- Tax treatment allocation7677**Ongoing royalties:**78- [ ] Royalty base (net sales, gross revenue, units)79- [ ] Rate (flat, tiered, per-product)80- [ ] Payment frequency (quarterly/annually)81- [ ] Accounting and reporting obligations with deadlines82- [ ] Audit rights (frequency, scope, cost allocation, underpayment penalty threshold)83- [ ] Late payment interest rate84- [ ] Minimum royalty provisions if applicable8586### 6. Confidentiality8788- [ ] Define Confidential Information (include agreement terms if required)89- [ ] Permitted disclosures: attorneys, accountants, court order, regulatory90- [ ] Compelled disclosure: prompt notice + cooperation on protective order91- [ ] Public announcement: mutual approval of press language92- [ ] Survival post-termination (typically 3–5 years; trade secrets indefinite)9394### 7. Representations, Warranties, and Indemnification9596| Party | Representations |97|---|---|98| Mutual | Authority to enter agreement; no conflict with existing obligations |99| Licensor | Ownership of licensed IP; right to grant license; no known third-party infringement (knowledge qualifier) |100| Licensee | Ability to perform obligations; compliance with applicable laws |101102**Indemnification:** scope of covered claims, notice requirements, control of defense, liability caps, consequential damages exclusion, "as-is" disclaimer where appropriate.103104### 8. Term, Termination, and Post-Termination105106| Provision | Settlement Component | License Component |107|---|---|---|108| Duration | Irrevocable on execution | Defined term or perpetual |109| Termination triggers | N/A | Material breach, non-payment, bankruptcy |110| Cure period | N/A | 30 days written notice (standard) |111| Post-termination | Release survives | Cease use, wind-down period, inventory sell-off |112| Surviving provisions | Release, confidentiality | Audit rights, accrued payments |113114**Critical:** License termination must NOT revive settled claims.115116### 9. Dispute Resolution117118| Step | Timeframe |119|---|---|120| Executive negotiation | 15–30 days |121| Mediation | 30–60 days |122| Binding arbitration or litigation | Per rules selected |123124Specify: governing law, venue/arbitration seat, arbitration rules (AAA, JAMS, ICC), prevailing party fee-shifting, jury trial waiver (if litigation path), whether settlement vs. license disputes use different mechanisms.125126### 10. General Provisions127128- [ ] Entire agreement / integration clause129- [ ] Amendment: written consent required130- [ ] Assignment restrictions (consent required; change-of-control trigger)131- [ ] Severability132- [ ] Waiver (no implied waiver from failure to enforce)133- [ ] Notice provisions with addresses and methods134- [ ] Counterparts and electronic signature authorization135- [ ] Signature blocks with officer name, title, date, authority confirmation136- [ ] Board approval / regulatory filing confirmation if required137138## Guidelines139140- **Release–license interaction** — Always address whether the release survives license termination. Ambiguity here risks revived claims.141- **Tax characterization** — Settlement payments and royalties differ in tax treatment. Flag for tax counsel.142- **Antitrust risk** — License-back provisions and field-of-use restrictions in settlement context may raise antitrust concerns. Flag if present.143- **Bankruptcy** — IP licenses receive special treatment under 11 U.S.C. § 365(n) [VERIFY]. Include licensee protective language.144- **Recording** — Patent and trademark licenses may require USPTO recording. Include cooperation obligation.145- **Internal consistency** — Cross-check defined terms, section cross-references, and numbering before final output.146- **No legal advice** — Flag all jurisdiction-specific provisions for attorney review. Settlement agreements require human oversight.
lev-os